Stay updated on PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.4 to v3.5.5, indicating a minor platform update. No study data or user-facing content appears to be affected.
    Difference
    0.1%
    Check dated 2026-06-05T13:41:42.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision history updated with a new entry for v3.5.4 and removal of v3.5.3, indicating a small metadata update to the page.
    Difference
    0.1%
    Check dated 2026-05-15T05:48:03.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a minor site software release rather than any change to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:59:47.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:30.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:16:16.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2 in the page footer.
    Difference
    0.1%
    Check dated 2026-03-12T02:18:30.000Z thumbnail image

Stay in the know with updates to PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PAC-1 in Refractory Metastatic Kidney Cancer Clinical Trial page.